Literature DB >> 34554315

Comparative measurement of D- and L-lactic acid isomers in vaginal secretions: association with high-grade cervical squamous intraepithelial lesions.

Christina Cordeiro Benevides de Magalhães1, Iara Moreno Linhares2, Laís Farias Masullo3,4, Renata Mírian Nunes Eleutério4,5, Steven S Witkin6, José Eleutério7,8,9.   

Abstract

PURPOSE: Identification of low-cost protocols to identify women at elevated susceptibility to develop cervical intra-epithelial abnormalities would aid in more individualized monitoring. We evaluated whether quantitation of the D- and L-lactic acid isomers in vaginal secretions could differentiate women with normal cervical epithelia from those with a low (LSIL) or high (HSIL) grade squamous intraepithelial lesion or with cervical cancer.
METHODS: Vaginal samples, collected from 78 women undetgoing cervical colposcopy and biopsy, were tested for pH, bacterial composition by Gram stain (Nugent score) and concentrations of D- and L-lactic acid by a colorimetric assay.
RESULTS: Subsequent diagnosis was 23 women with normal cervical epithelium, 10 with LSIL, 43 with HSIL and 2 with cervical cancer. Vaginal pH and Nugent score were comparable in all subject groups. The concentration of L-lactic acid, but not D-lactic acid, as well as the L/D-lactic acid ratio, were significantly elevated (p < 0.01) in women with HSIL and cervical cancer.
CONCLUSION: Comparative measurement of vaginal D- and L-lactic acid isomers may provide a low-cost alternative to identification of women with an elevated susceptibility to cervical abnormalities.
© 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Cervix uteri; Lactic acid isomers; Squamous intraepithelial lesions; Vagina

Mesh:

Substances:

Year:  2021        PMID: 34554315     DOI: 10.1007/s00404-021-06258-6

Source DB:  PubMed          Journal:  Arch Gynecol Obstet        ISSN: 0932-0067            Impact factor:   2.344


  15 in total

1.  The Lower Anogenital Squamous Terminology Standardization Project for HPV-Associated Lesions: background and consensus recommendations from the College of American Pathologists and the American Society for Colposcopy and Cervical Pathology.

Authors:  Teresa M Darragh; Terence J Colgan; J Thomas Cox; Debra S Heller; Michael R Henry; Ronald D Luff; Timothy McCalmont; Ritu Nayar; Joel M Palefsky; Mark H Stoler; Edward J Wilkinson; Richard J Zaino; David C Wilbur
Journal:  Arch Pathol Lab Med       Date:  2012-06-28       Impact factor: 5.534

2.  The vaginal microbiota, human papillomavirus and cervical dysplasia: a systematic review and network meta-analysis.

Authors:  J Norenhag; J Du; M Olovsson; H Verstraelen; L Engstrand; N Brusselaers
Journal:  BJOG       Date:  2019-07-17       Impact factor: 6.531

Review 3.  Contribution of Epithelial Cells to Defense Mechanisms in the Human Vagina.

Authors:  Iara M Linhares; Giovanni Sisti; Evelyn Minis; Gabriela B de Freitas; Antonio F Moron; Steven S Witkin
Journal:  Curr Infect Dis Rep       Date:  2019-08-01       Impact factor: 3.725

4.  A discrete population of squamocolumnar junction cells implicated in the pathogenesis of cervical cancer.

Authors:  Michael Herfs; Yusuke Yamamoto; Anna Laury; Xia Wang; Marisa R Nucci; Margaret E McLaughlin-Drubin; Karl Münger; Sarah Feldman; Frank D McKeon; Wa Xian; Christopher P Crum
Journal:  Proc Natl Acad Sci U S A       Date:  2012-06-11       Impact factor: 11.205

5.  Microbiota dysbiosis is associated with HPV-induced cervical carcinogenesis.

Authors:  Wojciech Kwasniewski; Maria Wolun-Cholewa; Jan Kotarski; Wojciech Warchol; Dorota Kuzma; Anna Kwasniewska; Anna Gozdzicka-Jozefiak
Journal:  Oncol Lett       Date:  2018-09-26       Impact factor: 2.967

6.  Effects of bacterial vaginosis and other genital infections on the natural history of human papillomavirus infection in HIV-1-infected and high-risk HIV-1-uninfected women.

Authors:  D Heather Watts; Melissa Fazzari; Melissa Fazarri; Howard Minkoff; Sharon L Hillier; Beverly Sha; Marshall Glesby; Alexandra M Levine; Robert Burk; Joel M Palefsky; Michael Moxley; Linda Ahdieh-Grant; Howard D Strickler
Journal:  J Infect Dis       Date:  2005-02-21       Impact factor: 5.226

7.  The vaginal microbiota and its association with human papillomavirus, Chlamydia trachomatis, Neisseria gonorrhoeae and Mycoplasma genitalium infections: a systematic review and meta-analysis.

Authors:  J Tamarelle; A C M Thiébaut; B de Barbeyrac; C Bébéar; J Ravel; E Delarocque-Astagneau
Journal:  Clin Microbiol Infect       Date:  2018-05-03       Impact factor: 8.067

Review 8.  The vaginal microbiota, human papillomavirus infection and cervical intraepithelial neoplasia: what do we know and where are we going next?

Authors:  Anita Mitra; David A MacIntyre; Julian R Marchesi; Yun S Lee; Phillip R Bennett; Maria Kyrgiou
Journal:  Microbiome       Date:  2016-11-01       Impact factor: 14.650

9.  Patients With LR-HPV Infection Have a Distinct Vaginal Microbiota in Comparison With Healthy Controls.

Authors:  Yunying Zhou; Lu Wang; Fengyan Pei; Mingyu Ji; Fang Zhang; Yingshuo Sun; Qianqian Zhao; Yatian Hong; Xiao Wang; Juanjuan Tian; Yunshan Wang
Journal:  Front Cell Infect Microbiol       Date:  2019-08-28       Impact factor: 5.293

10.  Influence of vaginal bacteria and D- and L-lactic acid isomers on vaginal extracellular matrix metalloproteinase inducer: implications for protection against upper genital tract infections.

Authors:  Steven S Witkin; Helena Mendes-Soares; Iara M Linhares; Aswathi Jayaram; William J Ledger; Larry J Forney
Journal:  mBio       Date:  2013-08-06       Impact factor: 7.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.